Bulk Manufacturer of Controlled Substances Application: Noramco, Inc., 60498-60499 [2014-23831]

Download as PDF 60498 Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices Salts of organic amino sulfonic acid explosive mixture. Salutes (bulk). Silver acetylide. Silver azide. Silver fulminate. Silver oxalate explosive mixtures. Silver styphnate. Silver tartrate explosive mixtures. Silver tetrazene. Slurried explosive mixtures of water, inorganic oxidizing salt, gelling agent, fuel, and sensitizer (cap sensitive). Smokeless powder. Sodatol. Sodium amatol. Sodium azide explosive mixture. Sodium dinitro-ortho-cresolate. Sodium nitrate explosive mixtures. Sodium nitrate-potassium nitrate explosive mixture. Sodium picramate. Special fireworks. Squibs. Styphnic acid explosives. T Tacot [tetranitro-2,3,5,6-dibenzo-1,3a,4,6a tetrazapentalene]. TATB [triaminotrinitrobenzene]. TATP [triacetonetriperoxide]. TEGDN [triethylene glycol dinitrate]. Tetranitrocarbazole. Tetrazene [tetracene, tetrazine, 1(5tetrazolyl)-4-guanyl tetrazene hydrate]. Tetrazole explosives. Tetryl [2,4,6 tetranitro-N-methylaniline]. Tetrytol. Thickened inorganic oxidizer salt slurried explosive mixture. TMETN [trimethylolethane trinitrate]. TNEF [trinitroethyl formal]. TNEOC [trinitroethylorthocarbonate]. TNEOF [trinitroethylorthoformate]. TNT [trinitrotoluene, trotyl, trilite, triton]. Torpex. Tridite. Trimethylol ethyl methane trinitrate composition. Trimethylolthane trinitrate-nitrocellulose. Trimonite. Trinitroanisole. Trinitrobenzene. Trinitrobenzoic acid. Trinitrocresol. Trinitro-meta-cresol. Trinitronaphthalene. Trinitrophenetol. Trinitrophloroglucinol. Trinitroresorcinol. Tritonal. U asabaliauskas on DSK5VPTVN1PROD with NOTICES Urea nitrate. W Water-bearing explosives having salts of oxidizing acids and nitrogen bases, sulfates, or sulfamates (cap sensitive). Water-in-oil emulsion explosive compositions. X Xanthamonas hydrophilic colloid explosive mixture. VerDate Sep<11>2014 17:15 Oct 06, 2014 Jkt 235001 Dated: September 26, 2014. B. Todd Jones, Director. dosage manufacturers. No other activity for this drug code is authorized for this registration. [FR Doc. 2014–23870 Filed 10–6–14; 8:45 am] Dated: September 25, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator. BILLING CODE 4410–FY–P [FR Doc. 2014–23833 Filed 10–6–14; 8:45 am] DEPARTMENT OF JUSTICE BILLING CODE 4410–09–P Drug Enforcement Administration [Docket No. DEA–392] DEPARTMENT OF JUSTICE Bulk Manufacturer of Controlled Substances Application: Johnson Matthey, Inc. Drug Enforcement Administration ACTION: Bulk Manufacturer of Controlled Substances Application: Noramco, Inc. Notice of application. Registered bulk manufacturers of the affected basic class, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before December 8, 2014. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, and dispensers of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to section 7 of 28 CFR pt. 0, subpt. R, App. In accordance with 21 CFR 1301.33(a), this is notice that on June 26, 2014, Johnson Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066–1742, applied to be registered as a bulk manufacturer of marihuana (7360), a basic class of controlled substance listed in schedule I. In reference to drug code 7360, the company plans to manufacture a synthetic version cannabidiol in bulk for sale to its customers, who are final DATES: PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 [Docket No. DEA–392] ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before December 8, 2014. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, and dispensers of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to section 7 of 28 CFR pt. 0, subpt. R, App. In accordance with 21 CFR 1301.33(a), this is notice that on July 16, 2014, Noramco, Inc., 1440 Olympic Drive, Athens, Georgia 30601, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: DATES: Controlled substance Gamma (2010). E:\FR\FM\07OCN1.SGM Hydroxybutyric 07OCN1 Schedule Acid I Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices 60499 (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of importers of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to section 7 of 28 CFR part. 0, subpart. R, App. In accordance with 21 CFR 1301.34(a), this is notice that on June 23, 2014, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665–2402, applied to be registered as an importer of the following basic classes of controlled substances: Schedule Controlled substance Schedule Codeine-N-oxide (9053) ............... Dihydromorphine (9145) ............... Morphine-N-oxide (9307) ............. Amphetamine (1100) .................... Methylphenidate (1724) ................ Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Morphine (9300) ........................... Oripavine (9330) ........................... Thebaine (9333) ........................... Opium tincture (9630) .................. Oxymorphone (9652) ................... Noroxymorphone (9668) .............. Alfentanil (9737) ........................... Sufentanil (9740) .......................... Carfentanil (9743) ......................... Tapentadol (9780) ........................ Fentanyl (9801) ............................ I I I II II II II II II II II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Dated: September 26, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2014–23831 Filed 10–6–14; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Cerilliant Corporation ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before November 6, 2014. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before November 6, 2014. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration asabaliauskas on DSK5VPTVN1PROD with NOTICES DATES: VerDate Sep<11>2014 17:15 Oct 06, 2014 Jkt 235001 Controlled substance 3-Fluoro-N-methylcathinone (3– FMC) (1233). Cathinone (1235) .......................... Methcathinone (1237) .................. 4-Fluoro-N-methylcathinone (4– FMC) (1238). Pentedrone (amethylaminovalerophenone (1246). Mephedrone (4-Methyl-Nmethylcathinone) (1248). 4-Methyl-N-ethylcathinone (4– MEC) (1249). Naphyrone (1258) ........................ N-Ethylamphetamine (1475) ........ N,N-Dimethylamphetamine (1480) Fenethylline (1503) ....................... Gamma Hydroxybutyric Acid (2010). Methaqualone (2565) ................... JWH–250 (1-Pentyl-3-(2methoxyphenylacetyl) indole) (6250). SR–18 and RCS–8 (1Cyclohexylethyl-3-(2methoxyphenylacetyl) indole) (7008). 5-Flouro-UR–144 and XLR11 [1(5-Fluoro-pentyl)-1H-indol-3yl](2,2,3,3tetramethylcyclopropyl) methanone (7011). AB–FUBINACA (N-(1-amino-3methyl-1-oxobutan-2-yl)-1-(4fluorobenzyl)-1H-indazole-3carboxamide) (7012). JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) (7019). ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1pentyl-1H-indazole-3carboxamide) (7035). APINACA and AKB48 N-(1Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (7048). JWH–081 (1-Pentyl-3-(1-(4methoxynaphthoyl) indole) (7081). PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 Schedule I I I I I I I I I I I I I I I I I I I I I Controlled substance SR–19 and RCS–4 (1-Pentyl-3[(4-methoxy)-benzoyl] indole (7104). JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) (7118). JWH–122 (1-Pentyl-3-(4-methyl-1naphthoyl) indole) (7122). UR–144 (1-Pentyl-1H-indol-3yl)(2,2,3,3tetramethylcyclopropyl)methanone (7144). JWH–073 (1-Butyl-3-(1-naphthoyl)indole) (7173). JWH–200 (1-[2-(4Morpholinyl)ethyl]-3-(1-naphthoyl) indole) (7200). AM–2201 (1-(5-Fluoropentyl)-3-(1naphthoyl) indole) (7201). JWH–203 (1-Pentyl-3-(2chlorophenylacetyl) indole) (7203). PB–22 (Quinolin-8-yl 1-pentyl-1Hindole-3-carboxylate) (7222). 5F–PB–22 (Quinolin-8-yl 1-(5fluoropentyl)-1H-indole-3-. carboxylate) (7225) ...................... Alpha-ethyltryptamine (7249) ....... Ibogaine (7260) ............................ CP–47,497 (5-(1,1Dimethylheptyl)-2-[(1R,3S)-3hydroxycyclohexyl-phenol) (7297). CP–47497 C8 Homologue (5(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) (7298). Lysergic acid diethylamide (7315) 2,5-Dimethoxy-4-(n)propylthiophenethylamine (2C– T–7) (7348). Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ..... Parahexyl (7374) .......................... Mescaline (7381) .......................... 2-(4-Elthylthio-2,5dimethoxyphenyl) ethanamine (2C–T–2) (7385). 3,4,5-Trimethoxyamphetamine (7390). 4-Bromo-2,5dimethoxyamphetamine (7391). 4-Bromo-2,5dimethoxyphenethylamine (7392). 4-Methyl-2,5dimethoxyamphetamine (7395). 2,5-Dimethoxyamphetamine (7396). JWH–398 (1-Pentyl-3-(4-chloro-1naphthoyl) indole (7398). 3,4-Methylenedioxyamphetamine (7400). 5-Methoxy-3,4methylenedioxyamphetamine (7401). N-Hydroxy-3,4methylendioxyamphetamine (7402). 3,4-Methylenedioxy-Nethylamphetamine (7404). 3,4Methylenedioxymethamphetamine (7405). E:\FR\FM\07OCN1.SGM 07OCN1 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I

Agencies

[Federal Register Volume 79, Number 194 (Tuesday, October 7, 2014)]
[Notices]
[Pages 60498-60499]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23831]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Noramco, 
Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before December 8, 2014.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/ODW, 
8701 Morrissette Drive, Springfield, Virginia 22152. Request for 
hearings should be sent to: Drug Enforcement Administration, Attention: 
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: 
    The Attorney General has delegated his authority under the 
Controlled Substances Act to the Administrator of the Drug Enforcement 
Administration (DEA), 28 CFR 0.100(b). Authority to exercise all 
necessary functions with respect to the promulgation and implementation 
of 21 CFR part 1301, incident to the registration of manufacturers, 
distributors, and dispensers of controlled substances (other than final 
orders in connection with suspension, denial, or revocation of 
registration) has been redelegated to the Deputy Assistant 
Administrator of the DEA Office of Diversion Control (``Deputy 
Assistant Administrator'') pursuant to section 7 of 28 CFR pt. 0, 
subpt. R, App.
    In accordance with 21 CFR 1301.33(a), this is notice that on July 
16, 2014, Noramco, Inc., 1440 Olympic Drive, Athens, Georgia 30601, 
applied to be registered as a bulk manufacturer of the following basic 
classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)...........  I

[[Page 60499]]

 
Codeine-N-oxide (9053).....................  I
Dihydromorphine (9145).....................  I
Morphine-N-oxide (9307)....................  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Oripavine (9330)...........................  II
Thebaine (9333)............................  II
Opium tincture (9630)......................  II
Oxymorphone (9652).........................  II
Noroxymorphone (9668)......................  II
Alfentanil (9737)..........................  II
Sufentanil (9740)..........................  II
Carfentanil (9743).........................  II
Tapentadol (9780)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.

    Dated: September 26, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-23831 Filed 10-6-14; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.